Statistics
Te Tari Pāngarau me te Tatauranga
Department of Mathematics & Statistics
Back to Our people

Professor Katrina Sharples

Office: Science III, room 238
Phone: 479-7782
Email: katrina.sharples@otago.ac.nz

** Also in the Department of Medicine **

Research Interests

I am a biostatistician, with a PhD in Biostatistics from the University of Washington, Seattle. I have fairly broad interests in statistical methods for clinical and epidemiological research, with particular expertise in clinical trials. I am the lead statistician for Cancer Trials New Zealand, the Pharmacoepidemiology Research Network and the Centre for International Health and am a member of the Otago Global Health Institute and the Centre for Translational Research in Cancer. My main areas of application are cancer, infectious disease and respiratory disease. I chair the Health Research Council Data Monitoring Committee. My time is divided between the Department of Mathematics and Statistics and the Department of Medicine.

Selected recent publications

  • Parkin, L., Sharples, K. J., Barson, D. J., & Blank, M.-L. (2017). Simvastatin dose and acute kidney injury without concurrent serious muscle injury: A nationwide nested case-control study. PLoS ONE, 12(7), e0182066. doi: 10.1371/journal.pone.0182066
  • Burns, K. E., Lo, W.-Y., Findlay, M. P., Sharples, K., Laking, G., & Helsby, N. A. (2016). High CYP2C19 phenotypic variability in gastrointestinal cancer patients. Cancer Chemotherapy & Pharmacology, 77, 195-204. doi: 10.1007/s00280-015-2923-4
  • Perez, D., Sharples, K. J., Broom, R., Jeffery, M., Proctor, J., Hinder, V., … Simpson, A., … Findlay, M. (2015). A randomised phase IIb trial to assess the efficacy of ReCharge ice cream in preventing chemotherapy-induced diarrhoea. Supportive Care in Cancer, 23(11), 3307-3315. doi: 10.1007/s00520-015-2755-0
  • Parkin, L., Sharples, K., Hernandez, R. K., & Jick, S. S. (2011). Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: Nested case-control study based on UK General Practice Research Database. BMJ, 342, d2139. doi: 10.1136/bmj.d2139
  • Broom, R. J., Hinder, V., Sharples, K., Proctor, J., Duffey, S., Pollard, S., … Findlay, M. P. N. (2015). Everolimus and zoledronic acid in patients with renal cell carcinoma with bone metastases: A randomized first-line phase II trial. Clinical Genitourinary Cancer, 13(1), 50-58. doi: 10.1016/j.clgc.2014.07.002